FDA approves J&J’s esketamine as stand-alone depression treatment

The move expands access to the novel mental health treatment, which has shown rapid symptom improvement for the past few years now.

The post FDA approves J&J’s esketamine as stand-alone depression treatment appeared first on Green Market Report.